Abstract

Hirschsprung disease is a heterogeneous genetic disorder, causative genes of which include the endothelin B receptor (ETB). To investigate the mutations of ETB in Hirschsprung disease, expression of the ETB gene in lymphoblastoid cells from patients and normal healthy adults was examined, and novel mutant transcripts were found. The mutant ETB gene transcripts lacked a 134-bp nucleotide sequence corresponding to exon 5, and some also contained a substitution from A to G at position 950 in exon 4, resulting in an amino acid substitution from glutamine (Q) to arginine (R). This substitution was suspected to be the result of RNA editing because it was not present in the genomic sequence. Transfection experiments using ETB minigenes containing the editing site with or without the gene for double-strand RNA deaminases (ADAR1 and ADAR2) revealed that the deaminases were involved in RNA editing. Furthermore, a c-Myc-tagged mutant ETB protein was not detected by Western blot analysis. The present results show that the mutant ETB transcripts were novel splice variants, which might not be translated, or that the products translated from splice variants might be quickly degraded, presumably because of their instability. The preferential production of this null function ETB by RNA editing/splicing could be involved in the etiology of some cases of Hirschsprung disease.

Highlights

  • Endothelins (ETs),1 one of which was originally discovered as an endothelium-derived vasoconstricting factor, comprise a family of three isopeptides, termed ET-1, ET-2, and ET-3

  • Mutations in the endothelin B receptor (ETB) gene may lead to Hirschsprung disease (HSCR) when ETB proteins are functionally altered

  • Among the reported ETB mutations, the mutation C109R resulted in a mutant ETB with a lowered affinity to ET-1, and the mutations W276C and S390R impaired intracellular signaling events [11]

Read more

Summary

Introduction

Endothelins (ETs), one of which was originally discovered as an endothelium-derived vasoconstricting factor, comprise a family of three isopeptides, termed ET-1, ET-2, and ET-3. They act on two subtypes of G protein-coupled receptors, ETA and ETB [1]. In the course of analyzing candidate genes for sporadic cases of Japanese HSCR patients, a novel transcript of the ETB gene was discovered. It was derived from splicing and/or RNA editing of the primary ETB transcript, and it occurred in one of three patients as well as in some normal subjects. The causal relationship of the production of this mutant ETB to HSCR was assessed

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.